Related Experiment Video
Updated: Oct 22, 2025

Transplantation Into the Mouse Ovarian Fat Pad
Published on: September 7, 2016
The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer
Delphine Fessart1,2,3, Jacques Robert4, Cecile Hartog4
1INSERM U1242, "Chemistry, Oncogenesis Stress Signaling", Université Rennes 1, Rennes, France. delphine.fessart@inserm.fr.
Abstract:
Epithelial ovarian cancer (EOC) is the most common gynecologic disorder. Even with the recent progresses made towards the use of new therapeutics, it still represents the most lethal gynecologic malignancy in women from developed countries.The discovery of the anterior gradient proteins AGR2 and AGR3, which are highly related members belonging to the protein disulfide isomerase (PDI) family, attracted researchers' attention due to their putative involvement in adenocarcinoma development. This review compiles the current knowledge on the role of the AGR family and the expression of its members in EOC and discusses the potential clinical relevance of AGR2 and AGR3 for EOC diagnosis, prognosis, and therapeutics.A better understanding of the role of the AGR family may thus provide new handling avenues for EOC patients.
Insights
Anterior gradient proteins AGR2 and AGR3 are implicated in epithelial ovarian cancer (EOC). Understanding their role may lead to new diagnostic and therapeutic strategies for this lethal gynecologic malignancy.
Area of Science:
- Gynecology
- Oncology
- Molecular Biology
Background:
- Epithelial ovarian cancer (EOC) is a leading cause of cancer death in women globally.
- Despite therapeutic advances, EOC remains highly lethal, necessitating novel treatment strategies.
- Anterior gradient (AGR) proteins, AGR2 and AGR3, are related to protein disulfide isomerase (PDI) and are implicated in adenocarcinoma development.
Purpose of the Study:
- To review the current understanding of AGR family proteins in EOC.
- To explore the expression patterns of AGR2 and AGR3 in EOC.
- To discuss the potential clinical utility of AGR2 and AGR3 in EOC management.
Main Methods:
- Literature review of studies on AGR proteins and EOC.
- Analysis of existing data on AGR2 and AGR3 expression in EOC tissues.
- Synthesis of information regarding the functional roles of AGR2 and AGR3 in cancer.
Main Results:
- AGR2 and AGR3 are expressed in EOC and may play a role in its pathogenesis.
- Expression levels of AGR2 and AGR3 could correlate with EOC diagnosis and patient outcomes.
- AGR proteins represent potential targets for novel EOC therapies.
Conclusions:
- The AGR family, particularly AGR2 and AGR3, is relevant to epithelial ovarian cancer.
- Further research into AGR proteins could uncover new diagnostic biomarkers and therapeutic targets for EOC.
- Targeting AGR family proteins may offer new avenues for managing EOC patients.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
Related Concept Videos
Cancer Cell Migration through Invadopodia
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mitogens and the Cell Cycle